Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus
Abstract
A dose-dependent decrease in infectivity was observed on introduction of eosinophils into suspensions of respiratory syncytial virus group B (RSV-B). This antiviral effect was reversed by ribonuclease inhibitor, suggesting a role for the eosinophil secretory ribonucleases. Recombinant eosinophil-der …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
amino acid sequence
Cells
Cultured
Molecular Sequence Data
cattle
sequence homology
amino acid
dose-response relationship
drug
eosinophils / physiology*
antiviral agents / pharmacology*
respiratory syncytial virus
human / drug effects*
human / genetics
j b domachowske
h f rosenberg
eosinophils / enzymology
ribonucleases*
pmid:9607820
doi:10.1086/515322
k d dyer
eosinophil-derived neurotoxin
placental hormones / pharmacology
proteins / pharmacology*
recombinant fusion proteins / pharmacology
ribonuclease
pancreatic / antagonists & inhibitors
pancreatic / pharmacology*
pancreatic / physiology
tumor cells
Access
Citation
ID:
113875
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
113875
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet